National Vision Holdings Inc. (EYE)
EYE vs. PODD: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either National Vision (EYE) or Insulet (PODD). But which of these two stocks presents investors with the better value opportunity right now?
Are Investors Undervaluing National Vision (EYE) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Strength Seen in National Vision (EYE): Can Its 7.2% Jump Turn into More Strength?
National Vision (EYE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EYE or SYK: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of National Vision (EYE) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
National Vision (EYE) Gains Market Share Despite Macro Woes
National Vision (EYE) continues to execute core growth initiatives and further invest in strengthening competitive advantages.
3 Retail Stocks That Could Collapse in the E-Commerce Shakeout
With multiple factors in play, a major shakeout is due in the e-commerce space. The rise of AI advances in logistics tech and the post-pandemic norm will play a huge role in driving e-commerce moving forward.
